Prophylactic interventions for hereditary breast and ovarian cancer risks and mortality in BRCA1/2 carriers

T Liu, J Yu, Y Gao, X Ma, S Jiang, Y Gu, W Ming - Cancers, 2023 - mdpi.com
Simple Summary Prophylactic interventions are critical for BRCA1/2 mutation carriers to
reduce the risks of hereditary breast and ovarian cancer (HBOC). This systematic review and …

[HTML][HTML] Preferences for COVID-19 Vaccines: Systematic Literature Review of Discrete Choice Experiments

Y Huang, S Feng, Y Zhao, H Wang… - JMIR Public Health and …, 2024 - publichealth.jmir.org
Background Vaccination can be viewed as comprising the most important defensive barriers
to protect susceptible groups from infection. However, vaccine hesitancy for COVID-19 is …

Pretesting discrete-choice experiments: a guide for researchers

NB Campoamor, CJ Guerrini, WB Brooks… - The Patient-Patient …, 2024 - Springer
Discrete-choice experiments (DCEs) are a frequently used method to explore the
preferences of patients and other decision-makers in health. Pretesting is an essential stage …

[HTML][HTML] Quantifying benefit-risk trade-offs toward prophylactic treatment among adult patients with hemophilia A in China: discrete choice experiment study

L Wang, S Liu, S Jiang, C Li, L Lu, Y Fang, S Li - JMIR Public Health and …, 2023 - jmir.org
Background: Hemophilia A is a chronic condition that requires meticulous treatment and
management. Patient preferences for prophylactic treatment can substantially influence …

Patient preferences in diagnostic imaging: a scoping review

TA Baird, DR Wright, MT Britto, EA Lipstein… - The Patient-Patient …, 2023 - Springer
Background As new diagnostic imaging technologies are adopted, decisions surrounding
diagnostic imaging become increasingly complex. As such, understanding patient …

Patient versus physician preferences for lipid‐lowering drug therapy: A discrete choice experiment

L Zhang, J Chen, Z Cao, M Zhang, R Ma… - Health …, 2024 - Wiley Online Library
Background The emergence of proprotein convertase subtilisin/kexin type 9 inhibitors
offered dyslipidemia patients an alternative to statins for lipid‐lowering treatment …

Blood donors' preferences toward incentives for donation in China

Y Wang, P Zhai, S Jiang, C Li, S Li - JAMA Network Open, 2023 - jamanetwork.com
Importance Blood donation is critical for health care systems, but donor retention remains
challenging. Understanding donors' preferences can inform incentive design and improve …

Stated Preferences of At-Risk Populations for the Treatment of Osteoporosis: A Systematic Review

EL Hinzpeter, L Nagendra, N Kairies-Schwarz… - The Patient-Patient …, 2024 - Springer
Introduction Poor adherence to anti-osteoporosis treatment is a well-recognized problem,
partly due to misalignment with patient preferences. In recent years, several quantitative …

Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia

S Fifer, J Godsell, S Opat, N Hamad, M Lasica… - BMC cancer, 2024 - Springer
Background Listening to patient voices is critical, in terms of how people experience their
condition as well as their treatment preferences. This research explored the patient journey …

Gauging Incentive Values and Expectations (GIVE) among Blood Donors for Nonmonetary Incentives: Developing a Preference Elicitation Instrument through …

Y Wang, P Zhai, Y Zhang, S Jiang, G Chen… - The Patient-Patient …, 2023 - Springer
Introduction Blood donation rates remain suboptimal in China necessitating the reform of the
current nonmonetary incentive system to motivate donors. This study aims to identify …